Recent Developments in Drug-Coated Balloons – Part 2
Use of Drug-coated Balloons in Coronary Arteries to Treat In-stent Restenosis Coronary artery in-stent restenosis (ISR) is observed in about 10 percent of patients who undergo a drug eluting stent (DES) implantation and in more than 30 percent of patients who undergo bare-metal stent (BMS) implantation. Three DEBs for the coronaries have now been granted FDA breakthrough device designation to help expedite the approval process. In July 2020, MedAlliance began enrollment [...]

